S
Sander Florman
Researcher at Mount Sinai Hospital
Publications - 241
Citations - 8099
Sander Florman is an academic researcher from Mount Sinai Hospital. The author has contributed to research in topics: Transplantation & Liver transplantation. The author has an hindex of 42, co-authored 213 publications receiving 6460 citations. Previous affiliations of Sander Florman include University Medical Center New Orleans & Georgetown University.
Papers
More filters
Journal ArticleDOI
A phase III study of belatacept versus cyclosporine in kidney transplants from extended criteria donors (BENEFIT-EXT study)
Antoine Durrbach,José Osmar Medina Pestana,Thomas C. Pearson,Flavio Vincenti,Valter Duro Garcia,Josep M. Campistol,M. del Carmen Rial,Sander Florman,A. Block,G. Di Russo,J Xing,P. Garg,Josep M. Grinyó +12 more
TL;DR: ECD kidney transplant recipients treated with belatacept‐based immunosuppression achieved similar patient/graft survival, better renal function, had an increased incidence of PTLD, and exhibited improvement in the cardiovascular/metabolic risk profile versus cyclosporine‐treated patients.
Journal ArticleDOI
Report of a national conference on liver allocation in patients with hepatocellular carcinoma in the United States.
Elizabeth A. Pomfret,Kenneth Washburn,Christoph Wald,Michael A. Nalesnik,David D. Douglas,Mark W. Russo,John P. Roberts,David J. Reich,Myron Schwartz,Luis Mieles,Fred T. Lee,Sander Florman,Francis Y. Yao,Ann M. Harper,Erick B. Edwards,Richard B. Freeman,John R. Lake +16 more
TL;DR: A national conference was held to better characterize the long‐term outcomes of liver transplantation for patients with hepatocellular carcinoma (HCC) and to assess whether it is justified to continue the policy of assigning increased priority for candidates with early‐stage HCC on the transplant waiting list in the United States.
Journal ArticleDOI
COVID-19 in solid organ transplant: A multi-center cohort study.
Olivia S Kates,Brandy Haydel,Sander Florman,Meenakshi Rana,Zohra S Chaudhry,Mayur Ramesh,Kassem Safa,Camille N. Kotton,Emily A. Blumberg,Behdad Besharatian,Sajal D Tanna,Michael G. Ison,Maricar Malinis,Marwan M. Azar,Robert M. Rakita,Jose A Morillas,Aneela Majeed,Afrah S Sait,Mario Spaggiari,Vagish Hemmige,Sapna A. Mehta,Henry J Neumann,Abbasali Badami,Jason D Goldman,Anuradha Lala,Marion Hemmersbach-Miller,Margaret E McCort,Valida Bajrovic,Carlos Ortiz-Bautista,Rachel J. Friedman-Moraco,Sameep Sehgal,Erika D. Lease,Cynthia E. Fisher,Ajit P. Limaye,UW Covid Sot Study Team +34 more
TL;DR: Age and underlying comorbidities rather than immunosuppression intensity-related measures were major drivers of mortality among SOT recipients hospitalized for COVID-19, and multiple measures of immunosppression intensity were not associated with mortality.
Journal ArticleDOI
One Hundred Nine Living Donor Liver Transplants in Adults and Children: A Single-Center Experience
Charles M. Miller,Gabriel Gondolesi,Sander Florman,Cal S. Matsumoto,Luis Muñoz,Tomoharu Yoshizumi,Tarik Artis,Thomas M. Fishbein,Patricia A. Sheiner,Leona Kim-Schluger,Thomas D. Schiano,Benjamin L. Shneider,Sukru Emre,Myron Schwartz +13 more
TL;DR: Living donor liver transplantation has become an important option for patients and has dramatically changed the approach to patients with liver failure and it is expected that living donor liver transplants will represent more than 50% of the authors' transplants within 3 years.
Journal ArticleDOI
COVID-19 and kidney transplantation: Results from the TANGO International Transplant Consortium.
Paolo Cravedi,Suraj Sarvode Mothi,Yorg Azzi,Meredith Haverly,Samira S. Farouk,María José Pérez-Sáez,María Dolores Redondo-Pachón,Barbara Murphy,Sander Florman,Laura Goldfarb Cyrino,Monica Grafals,Sandheep Venkataraman,Xingxing S. Cheng,Aileen X. Wang,Gianluigi Zaza,Andrea Ranghino,Lucrezia Furian,Joaquin Manrique,Umberto Maggiore,Ilaria Gandolfini,Nikhil Agrawal,Het Patel,Enver Akalin,Leonardo V. Riella +23 more
TL;DR: Hospitalized kidney transplant recipients with COVID‐19 have higher rates of acute kidney injury and mortality, and predictors of poor clinical outcomes were determined through multivariable analyses.